Correction: A synthetic cell-penetrating peptide derived from nuclear localization signal of EPS8 exerts anticancer activity against acute myeloid leukemia

Correction: J Exp Clin Cancer Res 37, 12 (2018)

https://doi.org/10.1186/s13046-018-0682-x

Following publication of the original article [1], an error was identified in Fig. 7; specifically:

• Figure 7f: slice (PBS-4) was occupied by a duplicate slice (PBS-6); the correct image is now used.

Fig. 7

Antitumor activity of CP-EPS8-NLS in a U937 xenograft model. a U937 cells (5 × 10⁶ per flank) were injected into the right flank of mice. When the volume of tumors reached 100 mm³, the mice were randomly divided into two groups (7 mice in each group). Then, PBS or CP-EPS8-NLS were intraperitoneally injected into the mice every other day. b The volume of each tumor was measured every other day for 22 days. c Body weight of the mice. d The volume of each tumor was measured after tumor extraction from the mice at the experimental endpoint. e Image of tumors excised from mice after 22 days of treatment. f EPS8 and Ki67 in tumor tissues at the end of the experiments using IHC staining

The correction does not have any effect on the results or conclusions of the paper.